Citigroup Inc Rockwell Medical, Inc. Transaction History

Citigroup Inc

$190 Billion
Q1 2025

A detailed history of Citigroup Inc transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Citigroup Inc holds 17,580 shares of RMTI stock, worth $19,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,580

Holding current value

$19,162

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 12, 2025	BUY	$1.13 - $2.33 $19,865 - $40,961	17,580 New	17,580 $19,000
Q3 2024 Nov 12, 2024	BUY	$1.67 - $4.4 $81 - $215	49 New	49 $0

Others Institutions Holding RMTI

# of Institutions

Shares Held

7.13M

Call Options Held

92.8K

Put Options Held

14.9K

Armistice Capital, LLC New York, NY

2.37M
Shares

$2.58 Million
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

1.21M
Shares

$1.31 Million
0.0% of portfolio
Globeflex Capital L P San Diego, CA

743K
Shares

$810,149
0.08% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

453K
Shares

$493,771
0.0% of portfolio
Marshall Wace, LLP London, X0

334K
Shares

$363,618
0.0% of portfolio

View Full List

About ROCKWELL MEDICAL, INC.

Ticker RMTI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 10,675,200
Market Cap $11.6M
Description
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...

More about RMTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account